# Immunocan funding: rounds and investors

> Immunocan has raised across 1 round since 2026. Investors include Vivo Capital, Gold Mine Multi Family Office and Kingray Capital. Every round with its source.

Source: https://millionrounds.com/company/immunocan (Millionrounds; every figure on the page links to its filing or article)

China · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Immunocan*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI Biotech Genomics

Raised 5 months ago

Funding summary Updated 26 Oct 2026

**Undisclosed** raised across 1 round since 2026, from 1 source

- **Latest round:** Series A May 2026
- **Led by:** Vivo Capital
- **Investors:** 4 (1 led)

See who backed them

## The rounds

- **May 2026** Series A **RMB250 million** [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Lead [Gold Mine Multi Family Office](https://millionrounds.com/fund/gold-mine-multi-family-office) [Kingray Capital](https://millionrounds.com/fund/kingray-capital) [TigerYeah Capital](https://millionrounds.com/fund/tigeryeah-capital) Reported by TechNode

## Everyone who backed them

[Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **1** round, led 1

[Gold Mine Multi Family Office](https://millionrounds.com/fund/gold-mine-multi-family-office) Family office **1** round

[Kingray Capital](https://millionrounds.com/fund/kingray-capital) VC firm **1** round

[TigerYeah Capital](https://millionrounds.com/fund/tigeryeah-capital) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=immunocan).

## Quick answers about Immunocan

### Who invested in Immunocan?

Immunocan's investors include Vivo Capital, Gold Mine Multi Family Office, Kingray Capital and TigerYeah Capital. Vivo Capital led its latest round.

### How much has Immunocan raised?

Immunocan has raised 1 round since 2026, none with a disclosed amount.

### When did Immunocan last raise?

Immunocan's most recent round was a Series A in May 2026, led by Vivo Capital.

### Who backed Immunocan first?

Immunocan's first round on record, in May 2026, was backed by Vivo Capital, Gold Mine Multi Family Office and Kingray Capital and 1 others.

### What stage is Immunocan at?

Immunocan's latest named round is a Series A, in May 2026.

### Where is Immunocan based?

Immunocan is based in China.

### Who led Immunocan's rounds?

Vivo Capital led the Series A in 2026.

## Companies like Immunocan

In the same sector, and raised in the last eighteen months.

[**DeepSeek** $24B · Oct 2026](https://millionrounds.com/company/deepseek)[**AGIBOT** $149M · Oct 2026](https://millionrounds.com/company/agibot)[**Infinigence AI** $344M · Oct 2026](https://millionrounds.com/company/infinigence-ai)[**NIMO** Oct 2026](https://millionrounds.com/company/nimo)[**Nutshell Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/nutshell-therapeutics)[**ByteDance** $33B · Sept 2026](https://millionrounds.com/company/bytedance)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app